Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today a partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback